Market Research Report
Heart Valve Devices Market (Product Type - Mechanical Heart Valves, Biological Heart Valves, and Transcatheter Heart Valves; End User - Hospitals and ASCs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
|Published by||Transparency Market Research||Product code||524363|
|Published||Content info||243 Pages
Delivery time: 1-2 business days
|Heart Valve Devices Market (Product Type - Mechanical Heart Valves, Biological Heart Valves, and Transcatheter Heart Valves; End User - Hospitals and ASCs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025|
|Published: September 22, 2017||Content info: 243 Pages||
Heart Valve Devices Market
(Product Type - Mechanical Heart Valves (Aortic Valves and Mitral Valves), Biological Heart Valves (Aortic Valves, Mitral Valves, Pulmonary Valves, and Tricuspid Valves), and Transcatheter Heart Valves (Aortic Valves, Mitral Valves, and Pulmonary Valves); End User - Hospitals and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.
This report studies the current as well as future prospects of the global heart valve devices market. Stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various heart valve devices, as well as new entrants planning to enter this market.
This research study analyzes the global market for heart valve devices in terms of revenue (US$ Mn) and volume (Units). For the research, 2016 has been considered as the base year and 2015 as the historical year, while all forecasts have been provided from 2017 to 2025. The global heart valve devices market has been studied on the basis of, heart valve device type, end users, and their regional as well as national markets in terms of revenue (US$ Mn) and volume (Units). The global heart valve devices market report comprises an elaborate executive summary that provides overall information about various segments of the market.
The report also includes technological trends covering the current developments, transcatheter mitral valves segment, valve-in-valve replacements, and upcoming technological trends in the global market. The report has covered the mergers and acquisitions in the global heart valve devices market for the period of 2010 to 2017, covering the payment details, and other associated conditions. The report also covers detailed analysis of regulatory pathway for pre-market approval and CE mark.
The detailed pricing analysis covering average selling prices by each heart valve devices type has been provided in the report. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global heart valve devices market for 2016. The report also provides detail company profiles of emerging market players operating in the global heart valve devices market.
The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the demand for heart valve devices in the global market. These factors would aid the stakeholders in establishing a strong foothold in the global heart valve devices market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and key technological trends in the heart valve devices market. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.
The heart valve devices market has been segmented as by product type, by end-user and by geography. The global heart valve devices market by type has been segmented into mechanical heart valves, biological heart valves and transcatheter heart valves. The mechanical heart valves segment is further divided into aortic valves and mitral valves. The biological heart valves are further segmented into aortic valves, mitral valves, pulmonary valves, and tricuspid valves. The transcatheter heart valves segment is classified into aortic valves, mitral valves, pulmonary valves. The end-user segment is categorized into hospitals and ambulatory surgical centers.
Geographically, the heart valve devices market has been categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, France, U.K., Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, Brazil, Mexico, South Africa, and GCC countries have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the heart valve devices market in various regions has been provided in this section.
The report provides a detailed outline/blueprint of the heart valve devices market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players.
The major players that are profiled in the report include Abbott, Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, JenaValve Technology, Inc., Medtronic, Neovasc, Inc., Sorin Group (LivaNova PLC), Micro Interventional Devices, Inc., , TTK HealthCare, and Lepu Medical Technology (Beijing) Co., Ltd. (Lepu Medical Group). The emerging players in the global heart valve devices market includes XELTIS, SYMETIS, Auto Tissue Berlin GmbH, and Novostia SA.
The global heart valve devices market has been segmented into: